Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99210875 | 9921087 | 5 | F | 20150916 | 20140225 | 20151001 | EXP | GB-RANBAXY-2014R1-78148 | RANBAXY | 40.00 | YR | F | Y | 0.00000 | 20151001 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99210875 | 9921087 | 1 | PS | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | 10 MG, DAILY | 77498 | 10 | MG | ||||||||
| 99210875 | 9921087 | 2 | SS | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | Unknown | 360 MG, DAILY | 0 | 360 | MG | ||||||||
| 99210875 | 9921087 | 3 | SS | RANITIDINE | RANITIDINERANITIDINE HYDROCHLORIDE | 1 | Unknown | 150 MG, BID | U | 0 | |||||||||
| 99210875 | 9921087 | 4 | SS | Ciclosporin | CYCLOSPORINE | 1 | Unknown | 50 MG, BID | U | 0 | 50 | MG | EAR DROPS | ||||||
| 99210875 | 9921087 | 5 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | UNK | 0 | EAR DROPS | |||||||||
| 99210875 | 9921087 | 6 | SS | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Unknown | 50 MG, QD (50MG NOCTE) | U | 0 | 50 | MG | |||||||
| 99210875 | 9921087 | 7 | SS | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | AT NIGHT | U | 0 | 50 | MG | ||||||||
| 99210875 | 9921087 | 8 | SS | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | 10 MG, NOCTURNAL, 2 WEEKS TRIAL | U | 0 | TABLET | ||||||||
| 99210875 | 9921087 | 9 | SS | SINGULAIR | MONTELUKAST SODIUM | 1 | AT NIGHT | U | 0 | 10 | MG | TABLET | |||||||
| 99210875 | 9921087 | 10 | SS | SINGULAIR | MONTELUKAST SODIUM | 1 | NOCTURNAL, 2 WEEKS TRIAL | U | 0 | 10 | MG | TABLET | |||||||
| 99210875 | 9921087 | 11 | SS | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | 10 MG, QD (10MG, NOCTE) | 0 | 10 | MG | TABLET | |||||||
| 99210875 | 9921087 | 12 | SS | SINGULAIR | MONTELUKAST SODIUM | 1 | UNK | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 99210875 | 9921087 | 1 | Chronic spontaneous urticaria |
| 99210875 | 9921087 | 2 | Chronic spontaneous urticaria |
| 99210875 | 9921087 | 3 | Chronic spontaneous urticaria |
| 99210875 | 9921087 | 4 | Chronic spontaneous urticaria |
| 99210875 | 9921087 | 5 | Product used for unknown indication |
| 99210875 | 9921087 | 6 | Chronic spontaneous urticaria |
| 99210875 | 9921087 | 8 | Chronic spontaneous urticaria |
| 99210875 | 9921087 | 11 | Chronic spontaneous urticaria |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 99210875 | 9921087 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 99210875 | 9921087 | Angioedema | |
| 99210875 | 9921087 | Chronic spontaneous urticaria | |
| 99210875 | 9921087 | Condition aggravated | |
| 99210875 | 9921087 | Drug ineffective | |
| 99210875 | 9921087 | Insomnia | |
| 99210875 | 9921087 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 99210875 | 9921087 | 1 | 201405 | 0 | ||
| 99210875 | 9921087 | 4 | 201405 | 0 | ||
| 99210875 | 9921087 | 5 | 201310 | 0 | ||
| 99210875 | 9921087 | 8 | 201309 | 0 | ||
| 99210875 | 9921087 | 9 | 201405 | 0 | ||
| 99210875 | 9921087 | 10 | 201309 | 0 | ||
| 99210875 | 9921087 | 11 | 201405 | 0 |